News & Events - Center for the Evaluation of Value and Risk in Health

Publications

AJMC

Communication of Launch Prices by Drug Companies, 2022-2024

Health Affairs Forefront

Do Medicare’s IPAY 2027 Negotiated Drug Prices Reflect Value For Money?

Journal of Neuromuscular Disease

US Health Plan Coverage of Neuromuscular Disease Therapies: An Assessment of Policy Availability and Restrictions

Health Affairs Forefront

The ‘Pharm-To-Table’ Movement For Prescription Drugs: Promising Or Performative?

Medical Decision Making

When Do Published Cost-Effectiveness Analyses Include Societal Costs? An Empirical Analysis, 2013–2023

Health Affairs Scholar

The Unintended Consequences of the Inflation Reduction Act on Biosimilar Market Incentives and Medicare Savings

The Journal of Pediatrics

Rapid Genome Sequencing Compared with a Gene Panel in Critically Ill Infants with a Suspected Genetic Disorder: An Economic Evaluation

JAMA

Variation in US Commercial Health Plan Coverage Restrictions for Cell and Gene Therapies

Journal of Pain and Symptom Management

Bereavement Experiences Among Parents of Children With Spinal Muscular Atrophy Type 1

View All Publications